As the global health crisis caused by COVID-19 continues, InBios is hard at work developing COVID-19 diagnostics. We received FDA EUA for our molecular rRT-PCR assay, and we continue development of ELISA and rapid test antibody test kits and a rapid antigen detection kit. Check this page frequently for updates.
We are also ready to support developers with CoV-2 recombinants and assay development. Inquire here for more information on how we can help.